Journallive -- FEARS have been voiced over the future of the pharmaceutical sector in a Northumberland town. Leading drugs company Merck Sharp and Dohme (MSD) has revealed 40 potential redundancies at its manufacturing and packaging plant in Cramlington because of an expected drop in demand for one of the medicines made there.
